← Back to Clinical Trials
Recruiting NCT07877480

NCT07877480 Predicting High-Risk Carotid Plaque: Integrating radioMics and biomEchanics

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07877480
Status Recruiting
Phase —
Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Condition Carotid Artery
Study Type INTERVENTIONAL
Enrollment 420 participants
Start Date 2025-09-01
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Radiomic features analysis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 420 participants in total. It began in 2025-09-01 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection

Eligibility Criteria

Inclusion Criteria: * Patients ≥ 18 years of age; * Affected by significant carotid atherosclerosis, whether symptomatic or asymptomatic (stenosis ≥ 70% according to ECST criteria). * Candidates for carotid ATE surgery. The criteria provided by the SICVE and ESVS guidelines will be followed for indications for surgery; * Preoperative imaging available; Exclusion Criteria: * Patients who have undergone previous carotid endarterectomy (ipsilateral to the affected side); * Patients who have undergone previous neck surgery involving cervical lymph node dissection; * Patients who have undergone previous neck radiation therapy; * Lack of preoperative imaging; * Patients unable to sign informed consent.

Frequently Asked Questions

Who can join the NCT07877480 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Carotid Artery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07877480 currently recruiting?

Yes, NCT07877480 is actively recruiting participants. Visit ClinicalTrials.gov or contact Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico to inquire about joining.

Where is the NCT07877480 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT07877480 clinical trial?

NCT07877480 is sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. The trial plans to enroll 420 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology